Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Identification of Predictive Immune Biomarkers Based on the Understanding of COVID-19 Pathogenesis to Influence Therapeutic Management

NCT04668170 is registered in ClinicalTrials.gov with University Hospital, Toulouse as lead sponsor.

NCT NCT04668170
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04668170 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Identification of Predictive Immune Biomarkers Based on the Understanding of COVID-19 Pathogenesis to Influence Therapeutic Management
Lead sponsor
University Hospital, Toulouse
Phase
Observational
Overall status
Completed
Start date
May 5, 2020
Completion date
May 2, 2023
Enrollment
304 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

covid-19